BANK OF AMERICA CORP /DE/ - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 41 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$74,646
+59.1%
6,054
+58.7%
0.00%
Q2 2023$46,925
+155.7%
3,815
+155.5%
0.00%
Q1 2023$18,349
-4.6%
1,493
-11.1%
0.00%
Q4 2022$19,241
+220.7%
1,679
+9.3%
0.00%
Q3 2022$6,000
-33.3%
1,5360.0%0.00%
Q2 2022$9,000
+12.5%
1,536
+24.3%
0.00%
Q1 2022$8,000
+60.0%
1,236
-1.7%
0.00%
Q4 2021$5,000
-50.0%
1,257
-37.2%
0.00%
Q3 2021$10,000
+11.1%
2,002
+48.2%
0.00%
Q2 2021$9,000
+12.5%
1,351
+2.7%
0.00%
Q1 2021$8,000
-11.1%
1,316
+0.1%
0.00%
Q4 2020$9,000
+50.0%
1,315
-8.5%
0.00%
Q3 2020$6,000
+20.0%
1,437
-8.9%
0.00%
Q2 2020$5,000
+66.7%
1,577
+4.8%
0.00%
Q1 2020$3,000
-72.7%
1,505
-56.2%
0.00%
Q4 2019$11,000
-45.0%
3,437
-23.2%
0.00%
Q3 2019$20,000
-16.7%
4,477
+11.1%
0.00%
Q2 2019$24,000
-11.1%
4,031
+3.4%
0.00%
Q1 2019$27,000
+440.0%
3,897
+179.0%
0.00%
Q4 2018$5,000
-37.5%
1,397
-10.7%
0.00%
Q3 2018$8,000
-93.2%
1,565
-93.4%
0.00%
Q2 2018$117,000
-8.6%
23,762
+49.5%
0.00%
Q1 2018$128,000
+245.9%
15,891
+338.6%
0.00%
Q4 2017$37,000
-77.6%
3,623
-68.0%
0.00%
Q3 2017$165,00011,3360.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders